£62.00

LAP Lambert Academic Publishing Immune Response of HCV Infected Patients to Virus Peptides: Immune Response, antiviral therapy, ELISPOT, 4a, core peptides, ribavirin

Price data last checked 43 day(s) ago - refreshing...

View at Amazon

We'll watch every seller, every day. One email when your price arrives.

It has never been this cheap. We have no record of a lower price.

£62 today · cheaper than every other day in the last 3 months

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey
↓ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 48 days • 48 data points (No recent data available)

Historical
Generating forecast...
£62.00 £58.90 £60.14 £61.38 £62.62 £63.86 £65.10 14 March 2026 25 March 2026 06 April 2026 18 April 2026 30 April 2026

Price Distribution

Price distribution over 48 days • 1 price levels

Days at Price
48 days 0 12 24 36 48 £62 Days at Price

Price Analysis

Most common price: £62 (48 days, 100.0%)

Price range: £62 - £62

Price levels: 1 different prices over 48 days

Description

Infection with hepatitis C virus is a serious worldwide problem which may lead to cirrhosis and hepatocellular carcinoma. The prevalence of HCV in Egypt is very high (about 20 % of the population). The only available treatment for HCV is the alpha interferon in combination with the guanosine analogue ribavirin. The immune response to this virus is insufficient in most infected individuals, thus the majority of whom develop chronic liver disease with viral persistence despite the presence of HCV-antibodies and cellular immune responses. Differences in the host cellular immune response to HCV may be important in viral clearance. The cellular immune response plays a major role in HCV infection and could represent an attractive target for therapeutic intervention. About the Author NAME: Ola Hassan Mohamed El- Habit Prof. of Genetics & Cell Biology, Head of Zoology Department, Faculty of Science, Helwan University

Product Specifications

Format
paperback
Domain
Amazon UK
Release Date
25 July 2012
Listed Since
27 July 2012

Barcode

No barcode data available

Similar Products You Might Like

Hepatitis C Virus II: Infection and Disease: 2
98% match

Hepatitis C Virus II: Infection and Disease: 2

Springer

£128.12 28 Feb 2026
Hepatitis C Virus II: Infection and Disease: 2
98% match

Hepatitis C Virus II: Infection and Disease: 2

Springer

£128.34 02 Feb 2026
Hepatitis C Virus Disease: Immunobiology and Clinical Applications
98% match

Hepatitis C Virus Disease: Immunobiology and Clinical Applications

Springer

£107.98 10 Jun 2026
Hepatitis C in Developing Countries: Current and Future Challenges
97% match

Hepatitis C in Developing Countries: Current and Future Challenges

Academic Press

£57.69 28 Apr 2026
Hepatitis C: Antiviral Drug Discovery and Development
97% match

Hepatitis C: Antiviral Drug Discovery and Development

Caister Academic Press Limited

£218.97 24 Jan 2026
Hepatitis C Virus: From Molecular Virology to Antiviral Therapy: 369 (Current Topics in Microbiology and Immunology, 369)
97% match

Hepatitis C Virus: From Molecular Virology to Antiviral Therapy: 369 (Current Topics in Microbiology and Immunology, 369)

Springer

£107.32 12 Jan 2026
Hepatitis C Infection as a Systemic Disease:Extra-HepaticManifestation of Hepatitis C, An Issue of Clinics in Liver Disease (Volume 21-3) (The Clinics: Internal Medicine, Volume 21-3)
97% match

Hepatitis C Infection as a Systemic Disease:Extra-HepaticManifestation of Hepatitis C, An Issue of Clinics in Liver Disease (Volume 21-3) (The Clinics: Internal Medicine, Volume 21-3)

Elsevier

£68.52 27 Feb 2026
Medication of HCV:Revolution of Direct Antiviral Agents and Sofosbuvir: Management of Chronic Hepatitis C:The Revolution of Direct Antiviral drugs(DAAs) and its Backbone; Sofosbuvir
97% match

Medication of HCV:Revolution of Direct Antiviral Agents and Sofosbuvir: Management of Chronic Hepatitis C:The Revolution of Direct Antiviral drugs(DAAs) and its Backbone; Sofosbuvir

LAP Lambert Academic Publishing

£5.32 23 Apr 2026
The Molecular Medicine of Viral Hepatitis (Molecular Medical Science Series)
97% match

The Molecular Medicine of Viral Hepatitis (Molecular Medical Science Series)

Wiley-Blackwell

£75.00 28 Feb 2026
Chronic Viral Hepatitis: Management and Control
97% match

Chronic Viral Hepatitis: Management and Control

Foster Academics

£72.50 04 Mar 2026
Hepatitis B Virus Infection: Molecular Virology to Antiviral Drugs: 1179 (Advances in Experimental Medicine and Biology, 1179)
97% match

Hepatitis B Virus Infection: Molecular Virology to Antiviral Drugs: 1179 (Advances in Experimental Medicine and Biology, 1179)

Springer

£114.42 24 Apr 2026
Hepatitis C: State of the Art at the Millennium: A Bound Compilation of Issues 1 and 2 of Seminars in Liver Disease (2000)
97% match

Hepatitis C: State of the Art at the Millennium: A Bound Compilation of Issues 1 and 2 of Seminars in Liver Disease (2000)

Thieme

£76.93 15 Apr 2026
A National Strategy for the Elimination of Hepatitis B and C: Phase Two Report
97% match

A National Strategy for the Elimination of Hepatitis B and C: Phase Two Report

National Academies Press

£95.92 19 Apr 2026
Humana Hepatitis B and D Protocols Vol 2 - Medical Book
97% match

Humana Hepatitis B and D Protocols Vol 2 - Medical Book

Humana

£30.21 28 Apr 2026
Humana Hepatitis B and D Protocols Vol 1 - Detection and Genotypes
97% match

Humana Hepatitis B and D Protocols Vol 1 - Detection and Genotypes

Humana

£31.40 29 Apr 2026
Chronic Hepatitis C Virus: Advances in Treatment, Promise for the Future
97% match

Chronic Hepatitis C Virus: Advances in Treatment, Promise for the Future

Springer

£100.10 08 Feb 2026
Humana Hepatitis B and D Protocols Vol 2 - Methods in Molecular Medicine
97% match

Humana Hepatitis B and D Protocols Vol 2 - Methods in Molecular Medicine

Humana

£80.70 30 Apr 2026
Overcoming Barriers to Eliminate Hepatitis C, An Issue of Infectious Disease Clinics of North America (Volume 32-2) (The Clinics: Internal Medicine, Volume 32-2)
97% match

Overcoming Barriers to Eliminate Hepatitis C, An Issue of Infectious Disease Clinics of North America (Volume 32-2) (The Clinics: Internal Medicine, Volume 32-2)

Elsevier

£73.86 09 Mar 2026
Chronic Viral Hepatitis: Diagnosis and Therapeutics (Clinical Gastroenterology)
97% match

Chronic Viral Hepatitis: Diagnosis and Therapeutics (Clinical Gastroenterology)

Humana

£84.88 09 May 2026
HEPATITIS C VIRUS (Virology Research Progress: Hepatology Research and Clinical Developments)
97% match

HEPATITIS C VIRUS (Virology Research Progress: Hepatology Research and Clinical Developments)

£66.80 23 Apr 2026
Hepatitis C Virus Treatment: Highly Effective Therapy with Direct Acting Antivirals and Associated Viral Resistance
97% match

Hepatitis C Virus Treatment: Highly Effective Therapy with Direct Acting Antivirals and Associated Viral Resistance

Springer

£72.56 10 Mar 2026
Hepatitis C: Methods and Protocols: 510 (Methods in Molecular Biology, 510)
97% match

Hepatitis C: Methods and Protocols: 510 (Methods in Molecular Biology, 510)

Humana

£102.16 18 Apr 2026
Modern Concepts of Acute and Chronic Hepatitis
97% match

Modern Concepts of Acute and Chronic Hepatitis

Springer

£41.15 22 Apr 2026
Viral Hepatitis (Proceedings in Life Sciences)
97% match

Viral Hepatitis (Proceedings in Life Sciences)

Springer

£77.23 16 Feb 2026